Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Morning-Evening Specific Longevity Food Supplement [Phase 1]

View source ↗

Summary

A Phase 1 trial of a morning-evening longevity food supplement for aging is ongoing but not recruiting, sponsored by the University of Primorska.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morning-Evening Specific Longevity Food Supplement

Snippet

Sponsor: University of Primorska | Conditions: Aging | Phase 1 | Status: ACTIVE_NOT_RECRUITING